India based firm Dr. Reddy’s Laboratories has introduced a new range of packaging for its syrup bottles and blister in order to make them patient-friendly. The company, in partnership with California-based design and consulting firm ...
Tags: Dr.Reddy's Laboratories, IDEO, blister packs, syrup bottles
The California State Assembly has passed a bill that restricts generic versions of medicines called biosimilars, upon their launch in the US. Biosimilars are medicines whose active drug substance is derived from living cells. They have ...
Tags: Biosimilar Drugs Bill, Medicine
Integrated global pharmaceutical company Dr. Reddy's Laboratories has introduced divalproex sodium extended - release tablets, USP, in 250mg and 500mg strengths in the US. The new FDA approved product is the generic version of Depakote ER ...
Oncobiologics and inVentiv Health have formed a global, strategic partnership for clinical development of biosimilar assets initially with a probable expansion to new molecules. The biosimilar assets include generic versions of Humira, ...
Tags: Oncobiologics, Biosimilars
US-based contract research organization (CRO) Pharmaceutical Product Development (PPD) is expanding its cGMP cell-based assay laboratory in Middleton, Wisconsin, US. The cell lab facility has been added with an approximate 6,800ft2 space, ...
Pfizer and Protalix BioTherapeutics have obtained approval from the Brazilian National Health Surveillance Agency for Uplyso (alfataliglicerase) as type I Gaucher disease therapy. Uplyso, referred to as Elelyso (taliglucerase alfa) ...
Tags: Pfizer, Protalix, Protalix BioTherapeutics
India-based global pharmaceutical company Dr. Reddy's Laboratories has launched Zoledronic Acid injection (4 mg/5 mL), following the approval of its abbreviated new drug application (ANDA) from the Food and Drug Administration, in the US. ...
Tags: pharmaceutical company, pharmaceutical services, pharmaceutical
Complementing the Expanded Biopharmaceutical Platform Solution are New Charged Surface Hybrid Particle Column and GlycoWorks Kit for Glycan Preparation. Waters Corporation have reinforced its commitment to advancing biotherapeutic ...
The increasing number of consolidations and in-licensing agreements between Multinational Corporations (MNC) and Indian companies highlights the growing significance of the country’s pharmaceutical market, states business intelligence ...
Dr. Reddy's Laboratories, an integrated global pharmaceutical company, has introduced Metoprolol Succinate extended-release (ER) tablets of 25mg, 50mg, 100mg and 200mg strengths in the US. The bioequivalent generic version of ...
Tags: Toprol-XL, metoprolol succinate, ER
AbD Serotec, MorphoSys' division for research and diagnostic antibodies, is set to introduce a series of the human combinatorial antibody library (HuCAL) anti-drug antibodies supporting the development of novel antibody therapeutics. The ...
Tags: AbD Serotec, HuCAL Anti-Drug Antibodies, antibody therapeutics, MorphoSys
Daiichi Sankyo has signed an exclusive agreement with Coherus BioSciences to develop and commercialize biosimilar candidates in certain Asian countries including Japan. The collaboration will focus on the development, manufacturing and ...
Tags: Daiichi Sankyo, Coherus BioSciences, biosimilar candidates
Biocon has invested in new integrated research and development centre, Biocon Research Center (BRC), in South-East Asia to conduct research on biologics that will deal with unmet medical needs. The 200,000ft2 will accommodate the ...
Tags: Biocon, invested, BRC, research on biologics, South-East Asia